Allergy And Infectious Diseases Research obligations in FY2026

What the Allergy And Infectious Diseases Research × FY2026 join is

Two tables meet. One table is CFDA 93.855 (Allergy And Infectious Diseases Research). The other is fiscal year 2026. $637,121,933.26 is the obligation aggregate for rows that carry both keys on the yearlyTrend table. The FY2026 cell is 1.8% of the program-wide $36,365,364,946.68 book on 13,068 awards. The remaining catalog dollars sit on other fiscal-year rows this page does not reprint. This page is that program–year join, not a patient census, a lab directory, a trial-enrollment table, or a disease ranking. The join does not prove that fiscal year 2026 caused Allergy And Infectious Diseases Research activity, only that USAspending coded the two keys together. FEC donation tables do not fund these USAspending obligations.

SpendingVault indexes the cell from USAspending.gov. The catalog title on the program side is ALLERGY AND INFECTIOUS DISEASES RESEARCH. The year on the other side is federal fiscal year 2026. Neither label is a contractor, a place of performance, or an awarding-agency code — this packet publishes no awarding agency and no named recipients. Parent without the year: /programs/93.855/ (CFDA 93.855). Parent without the CFDA: /fiscal-years/2026/ (FY2026 federal spending). 479 FY2026 awards make this a research-award file, still not a count of laboratories or investigators. Outlays are not this field.

Reading ALLERGY AND INFECTIOUS DISEASES RESEARCH without treating it as a score

CFDA 93.855 is the Catalog of Federal Domestic Assistance identifier for Allergy And Infectious Diseases Research. The official title is ALLERGY AND INFECTIOUS DISEASES RESEARCH. The program-wide obligation total in this extract is $36,365,364,946.68 across 13,068 awards. That figure is a program rollup, not a second headline for the FY2026 cell unless the two amounts match. Do not treat $36,365,364,946.68 as cash Treasury already sent. SpendingVault does not grade program performance. Do not mix aging research (93.866), arthritis research (93.846), or cancer detection research (93.394) into this 93.855 cell. Mixing those other keys into $637,121,933.26 would invent a combined total the packet never computed.

Open CFDA 93.855 at /programs/93.855/ for the program hub. That page is not this join: it can include other fiscal years if the extract lists them, and it is still obligations rather than outlays. This ties page stays on CFDA 93.855 in FY2026 only. Campaign-finance filings do not fund these USAspending obligations. Unique recipients remain unpublished. Later bulk files can move both the dollars and the 479-award count without changing the join keys.

FY2026 as the Allergy And Infectious Diseases Research yearlyTrend cell

Federal fiscal year 2026 is the time key on this yearlyTrend row. The year hub FY2026 federal spending at /fiscal-years/2026/ rolls up every program that year in the index, not only Allergy And Infectious Diseases Research. Reading $637,121,933.26 as all FY2026 federal obligations would over-read this cell. The join is one CFDA inside one fiscal year, not a Budget Appendix score and not a Treasury cash statement. Agency splits, place-of-performance maps, and recipient UEIs are omitted from this packet.

479 FY2026 awards as a CFDA table, not a census

The extract lists 479 awards on the Allergy And Infectious Diseases Research × FY2026 table. That is an award-record count for this yearlyTrend cell, not a count of laboratories or investigators. Unique recipients are unpublished. Continuations and modifications can add lines without naming a new organization. Dividing $637,121,933.26 by 479 is not published here as a typical award size, because the packet does not say the rows are comparable. The program-wide award count is 13,068, a different denominator.

Obligations versus outlays on CFDA 93.855

An obligation is a legal commitment. An outlay is a payment. $637,121,933.26 is the former. Citing it as cash already cleared on Allergy And Infectious Diseases Research in FY2026 over-reads the field. Keep $637,121,933.26 labeled as Allergy And Infectious Diseases Research obligations in fiscal year 2026. No named contractors or labs or investigators appear here. Quote Allergy And Infectious Diseases Research and FY2026 with $637,121,933.26. Keep CFDA 93.855 in the citation.

Budget justifications and press releases are not the source of this cell. If a chart mixes a different CFDA with FY2026 or a different fiscal year with Allergy And Infectious Diseases Research, the chart has left this join. Do not mix aging research (93.866), arthritis research (93.846), or cancer detection research (93.394) into this 93.855 cell. Correlation with news headlines is not causation.

How to step off the Allergy And Infectious Diseases Research FY2026 pair

Open /programs/93.855/ for CFDA 93.855, /fiscal-years/2026/ for FY2026 federal spending, /programs/ for All programs, and /ties/ for All spending ties. Those parents are larger than this cell. Keep both join sides on the same line as $637,121,933.26. USAspending.gov remains the source. A ties page exists because two tables meet. One table is CFDA 93.855. The other is fiscal year 2026. $637,121,933.26 is the obligation sum on that intersection, not a forecast and not a claim that Allergy And Infectious Diseases Research caused any outcome statistic to move.

Step off this pair through the internal links. Keep Allergy And Infectious Diseases Research and FY2026 together when citing $637,121,933.26. CFDA 93.855's program-wide award-record count is 13,068, not a FY2026-only census of labs or investigators. Obligations of $637,121,933.26 are not outlays. Original filings remain on USAspending.gov for this 93.855 × FY2026 pair. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished. Quote CFDA 93.855, fiscal year 2026, and $637,121,933.26 in one sentence.

Questions

How large is the Allergy And Infectious Diseases Research × FY2026 USAspending cell?

USAspending.gov records $637,121,933.26 in CFDA 93.855 obligations tagged to fiscal year 2026 across 479 awards. That cell is 1.8% of the program-wide $36,365,364,946.68 book, not an outlay. The pair is Allergy And Infectious Diseases Research plus FY2026.

Do 479 awards mean a count of laboratories or investigators?

No. 479 is an FY2026 award-record count on a research-award file. The program-wide extract lists 13,068 awards. Recipients are unpublished. The count is not a count of laboratories or investigators. USAspending.gov remains the source for this pair. Unique recipients remain unpublished on this 93.855 × FY2026 join.

Is Allergy And Infectious Diseases Research in FY2026 an outlay?

No. $637,121,933.26 is an obligation aggregate. Outlays are unpublished. Payments from the Treasury can lag or differ. FEC donations do not fund this USAspending cell. Original filings remain on USAspending.gov. The program-wide book is $36,365,364,946.68 on 13,068 awards, a different rollup.

How do I leave this Allergy And Infectious Diseases Research FY2026 join?

/programs/93.855/ is the program parent. /fiscal-years/2026/ is the FY2026 parent. /programs/ lists programs. /ties/ lists other pairs. Prefer those tables after later ingests; this page quotes Allergy And Infectious Diseases Research × FY2026 at $637,121,933.26. Keep CFDA 93.855 in the citation alongside fiscal year 2026.